Nurix Therapeutics, Inc. (NRIX)
14.92
-0.13
(-0.86%)
USD |
NASDAQ |
Mar 19, 16:00
14.89
-0.03
(-0.20%)
After-Hours: 06:31
Nurix Therapeutics EPS Diluted (Quarterly) : -0.8226 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8824 |
| Stoke Therapeutics, Inc. | -0.9922 |
| Immunome, Inc. | -0.7516 |
| Gilead Sciences, Inc. | 1.742 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -78.22M |
| Revenue (Quarterly) | 13.58M |
| Total Expenses (Quarterly) | 91.80M |
| Enterprise Value | 997.21M |
| Gross Profit Margin (Quarterly) | 65.89% |
| Profit Margin (Quarterly) | -576.1% |
| Earnings Yield | -20.39% |
| Normalized Earnings Yield | -20.39 |